［1］ARNETH B.Tumor Microenvironment［J］.Medicina(Kaunas)，2019，56(1):15.
［2］HUI LL，CHEN Y.Tumor microenvironment：Sanctuary of the devil［J］.Cancer Lett，2015，368(1):7-13.
［3］PELLIZZARI G，HOSKIN C，CRESCIOLI S，et al.IgE reprograms alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states［J］.EBiomedicine，2019，43:67-81.
［4］AMIN R，MOURCIN F，UHEL F，et al.DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma［J］.Blood，2015，126(16):1911-1920.
［5］JORDAN RE，FAN X，SALAZAR G，et al.Proteinase-nicked IgGs：an unanticipated target for tumor immunotherapy［J］.Oncoimmunology，2018，7(9):e1480300.
［6］CAO Y，SUN Y，POIRIER S，et al.Isolation and partial characterization of a transformation-associated sequence from human nasopharyngeal carcinoma［J］.Mol Carcinog，1991，4(4):297-307.
［7］CUI M，YOU L，ZHENG B，et al.High expression of cancer-derived glycosylated immunoglobulin G predicts poor prognosis in pancreatic ductal adenocarcinoma［J］.J Cancer，2020，11(8):2213-2221.
［8］GENG ZH，YE CX，HUANG Y，et al.Human colorectal cancer cells frequently express IgG and display unique Ig repertoire［J］.World J Gastrointest Oncol，2019，11(3):195-207.
［9］TAUBE JM，GALON J，SHOLL LM，et al.Implications of the tumor immune microenvironment for staging and therapeutics［J］.Mod Pathol，2018，31(2):214-234.
［10］BINNEWIES M，ROBERTS EW，KERSTEN K，et al.Understanding the tumor immune microenvironment(TIME) for effective therapy［J］.Nat Med，2018，24(5):541-550.
［11］GALLI F，AGUILERA JV，PALERMO B，et al.Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy［J］.J Exp Clin Cancer Res，2020，39(1):89.
［12］PARK EG，PYO SJ，CUI Y，et al.Tumor immune microenvironment lncRNAs［J］.Brief Bioinform，2022，23(1):bbab504.
［13］LEI X，LEI Y，LI JK，et al.Immune cells within the tumor microenvironment：Biological functions and roles in cancer immunotherapy［J］.Cancer Lett，2020，470:126-133.
［14］RUFFIN AT，CILLO AR，TABIB T，et al.B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma［J］.Nat Commun，2021，12(1):3349.
［15］SCHMIDT M，BOHM D，VON TORNE C，et al.The humoral immune system has a key prognostic impact in node-negative breast cancer［J］.Cancer Res，2008，68(13):5405-5413.
［16］PEPPAS I，GEORGE G，SOLLIE S，et al.Association of serum immunoglobulin levels with solid cancer：A systematic review and Meta-analysis［J］.Cancer Epidemiol Biomarkers Prev，2020，29(3):527-538.
［17］TSOU P，KATAYAMA H，OSTRIN EJ，et al.The emerging role of B cells in tumor immunity［J］.Cancer Res，2016，76(19):5597-5601.
［18］ZHANG B，VOGELZANG A，MIYAJIMA M，et al.B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity［J］.Nature，2021，599(7885):471-476.
［19］FRIDMAN WH，PETITPREZ F，MEYLAN M，et al.B cells and cancer：To B or not to B［J］.J Exp Med，2021，218(1):e20200851.
［20］VELTRI RW，KIKTA VA，WAINWRIGHT WH，et al.Biologic and molecular characterization of the IgG serum blocking factor(SBF-IgG) isolated from sera of patients with EBV-induced infectious mononucleosis［J］.J Immunol，1981，127(1):320-328.
［21］AFFARA NI，RUFFELL B，MEDLER TR，et al.B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas［J］.Cancer Cell，2014，25(6):809-821.
［22］HU DS，ZHENG H，LIU HD，et al.Immunoglobulin expression and its biological significance in cancer cells［J］.Cell Mol Immunol，2008，5(5):319-324.
［23］CHI XY，LI Y,QIU XY.V(D)J recombination，somatic hypermutation and class switch recombination of immunoglobulins：mechanism and regulation［J］.Immunology，2020，160(3):233-247.
［24］VIDARSSON G，DEKKERS G,RISPENS T.IgG subclasses and allotypes：from structure to effector functions［J］.Front Immunol，2014，5:520.
［25］HARADA K,NAKANUMA Y.Cholangiocarcinoma with respect to IgG4 reaction［J］.Int J Hepatol，2014，2014:803876.
［26］MIYATANI K，SAITO H，MURAKAMI Y，et al.A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis［J］.Virchows Arch，2016，468(5):549-557.
［27］BIANCHINI R，KARAGIANNIS SN，JORDAKIEVA G，et al.The role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer［J］.Int J Mol Sci，2020，21(14):5017.
［28］CRESCIOLI S，CORREA I，KARAGIANNIS P，et al.IgG4 characteristics and functions in cancer immunity［J］.Curr Allergy Asthma Rep，2016，16(1):7.
［29］JOSEPHS DH，BAX HJ，DODEV T，et al.Anti-folate receptor-alpha IgE but not IgG recruits macrophages to attack tumors via TNFalpha/MCP-1 signaling［J］.Cancer Res，2017，77(5):1127-1141.
［30］QIU XY，ZHU XH，ZHANG L，et al.Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells［J］.Cancer Res，2003，63(19):6488-6495.
［31］BABBAGE G，OTTENSMEIER CH，BLAYDES J，et al.Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines［J］.Cancer Res，2006，66(8):3996-4000.
［32］CHEN ZS，HUANG XR，YE JX，et al.Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades［J］.Cancer，2010，116(8):1953-1963.
［33］SHENG ZZ，LIU Y，QIN CP，et al.IgG is involved in the migration and invasion of clear cell renal cell carcinoma［J］.J Clin Pathol，2016，69(6):497-504.
［34］ZHENG H，LI M，LIU HD，et al.Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells［J］.Cell Biol Int，2007，31(1):82-87.
［35］WANG ZH，GENG ZH，SHAO WW，et al.Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells［J］.Cell Mol Immunol，2020，17(11):1148-1162.
［36］WANG JY，HUANG CC，ZHOU JY，et al.Causal link between immunoglobulin G glycosylation and cancer：A potential glycobiomarker for early tumor detection［J］.Cell Immunol，2021，361:104282.
［37］LIU WT，JI Z，WU BR，et al.Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44［J］.FEBS Lett，2021，595(17):2290-2302.
［38］RASHID S，SONG DZ，YUAN JB，et al.Molecular structure，expression，and the emerging role of Siglec-15 in skeletal biology and cancer［J］.J Cell Physiol，2022，237(3):1711-1719.
［39］MIAO S，SHU D，ZHU Y，et al.Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcgammaRⅡa［J］.Cell Death Dis，2019，10(2):87.
［40］REN W，ZHENG H，LI M，et al.A functional single nucleotide polymorphism site detected in nasopharyngeal carcinoma-associated transforming gene Tx［J］.Cancer Genet Cytogenet，2005，157(1):49-52.